Sano Genetics and Quest Diagnostics to streamline trial referrals and stratify patient subsets to identify those more likely to respond to treatment Company to initiate trial in early 2025, serving as ...
Penn Ovarian Cancer Research Center and Basser Center for BRCA, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback